When applying the same combination of variables from model (I) to explain dimensional outcomes, no significant association was found between depression, or functional outcome, and NR3C1 mRNA or cortisol, adjusted for age, sex, cannabis use, and antipsychotic intake. This evidence concerns the gene NR3C1 and depressive symptom measurement.